FIGURE
Figure 3
- ID
- ZDB-FIG-211002-42
- Publication
- Chen et al., 2021 - Protective Effects and Mechanisms of Procyanidins on Parkinson's Disease In Vivo and In Vitro
- Other Figures
- All Figure Page
- Back to All Figure Page
Figure 3
Figure 3. Effects of PCs on Nrf2/ARE pathway in MPP+-induced PC12 cells. (a) Protein levels of Nrf2 and Keap-1, as determined by Western blotting; (b) Nrf2/GAPDH protein relative expression (ratio to control); (c) Keap1/GAPDH protein relative expression (ratio to control); (d) protein expression levels of nuclear Nrf2 and cytoplasmic Nrf2, as determined by Western blotting; (e) nuclear Nrf2/LaminB protein relative expression (ratio to control); (f) cytoplasmic Nrf2/GAPDH protein relative expression (ratio to control); (g) protein levels of HO-1, NQO1, GCLC and GCLM, as determined by Western blotting; (h) HO-1/GAPDH protein relative expression (ratio to control); (i) NQO1/GAPDH protein relative expression (ratio to control); (j) GCLC/GAPDH protein relative expression (ratio to control); (k) GCLM/GAPDH protein relative expression (ratio to control). F and p values of the one-way analysis of variance are presented above each chart. The results of Tukey’s post hoc test are presented for selected comparisons: ns, p > 0.05; *, p < 0.05; **, p < 0.01; the error bars are SD.
|
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Molecules